A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Mercy Ships Announces the Global Mercy, World’s Largest NGO Hospital Ship – Plans to Sail Late 2021

October 6, 2020

Mercy Ships announced a first look at the construction of the world’s largest NGO hospital ship which plans to sail to Africa in late 2021 under the name of Global Mercy.

Mercy Ships, a faith-based global organization powered by charitable donors and volunteers, has been providing world-class surgical care to those in need for more than 40 years, free of charge.

“The Global Mercy will be a true modern marvel— a fully custom-built hospital ship with customized instruments, state-of-the-art technology and highly-trained talent of a modern hospital,” said Rosa Whitaker, president of Mercy Ships. “It also represents a unique call-to-action for anyone called to serve, and it presents the opportunity for people to use their skill set to positively impact global healthcare.”

According to the Lancet Global Surgery 2030 Report, an estimated number of 16.9 million people die yearly due to lack of access to surgical care. Over 93 percent of the population of sub-Saharan Africa do not have access to safe and timely surgery.1 As COVID-19 threatens the stability of already fragile healthcare systems globally, the need to provide basic life-saving care is greater than ever, especially in low-to-middle income countries. The Global Mercy will deliver a safe and clean environment to various African nations, providing help and resources from some of the most well-trained physicians in the world. Over the vessel’s 50 year expected lifespan, it is estimated that more than 150,000 lives will be changed onboard through surgery alone.

In addition to providing surgeries, the Global Mercy will be outfitted with state-of-the-art training spaces including a simulation lab with virtual and augmented reality, mannequins and other training tools and simulated post-op care space, which allow trainers to simulate local conditions and limitations in order to teach best practices in low-resource environments.

The 174-meter, 37,000-ton ship will have six operating rooms and house over 600 volunteers from around the globe representing many disciplines including surgeons, maritime crew, cooks, teachers, electricians, the host staff and more. The ship will also feature a 682-seat auditorium, student academy, gymnasium, pool, café, shop and library – all of which have been designed to accommodate up to 950 crew onboard when docked in port.

The Global Mercy will join the current flagship Africa Mercy, more than doubling the impact of volunteers and services provided by the charity. For more information about Mercy Ships, updates on Global Mercy or how to volunteer or donate, please visit here.

Mercy Ships uses hospital ships to deliver free, world-class healthcare services, capacity building, and sustainable development to those with little access in the developing world. Founded in 1978 by Don and Deyon Stephens, Mercy Ships has worked in more than 55 developing countries, providing services valued at more than $1.7 billion and directly benefitting more than 2.8 million people. Our ships are crewed by volunteers from over 50 nations, with an average of over 2000 volunteers each year. Professionals including surgeons, dentists, nurses, healthcare trainers, teachers, cooks, seamen, engineers, and agriculturalists donate their time and skills. With 16 national offices and an Africa Bureau, Mercy Ships seeks to transform individuals and serve nations.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy